Related Experiment Video
Updated: Jun 12, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Molecular probes for malignant melanoma imaging
Gang Ren1, Ying Pan, Zhen Cheng
1Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University, Stanford, CA 94305-5344, USA.
New molecular probes offer improved specificity for detecting and managing malignant melanoma. These targeted approaches complement existing imaging techniques, paving the way for personalized melanoma treatment strategies.
Area of Science:
- Oncology
- Medical Imaging
- Molecular Biology
Background:
- Malignant melanoma is a deadly cancer, especially when diagnosed late.
- Current imaging methods like (18)F-FDG PET lack melanoma specificity.
- There is a need for novel molecular probes for melanoma detection and management.
Purpose of the Study:
- To review molecular probes targeting diverse melanoma biomarkers.
- To assess the potential of these probes in improving melanoma diagnosis and treatment.
- To highlight advancements in molecular imaging for malignant melanoma.
Main Methods:
- Literature review of molecular probes for melanoma.
- Categorization of probes based on targeted biomarkers (e.g., metabolism, angiogenesis, MC1R, melanin).
- Analysis of probe specificity and potential clinical applications.
Main Results:
- Development of probes targeting general melanoma events (metabolism, angiogenesis, hypoxia, apoptosis).
- Investigation of probes targeting specific melanoma-associated molecules (MC1R, melanin) showing high specificity.
- Summary of various molecular probes for melanoma biomarker detection.
Conclusions:
- Molecular probes targeting specific melanoma biomarkers show promise for enhanced detection.
- These targeted probes can complement existing imaging modalities.
- Advancements in molecular probes may lead to personalized management of malignant melanoma.
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019